Maria Teresa Petrucci
Roma Tre University(IT)Policlinico Umberto I(IT)Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari(IT)5T Torino (Italy)(IT)Ospedale A. Perrino(IT)Torino e-district(IT)Sapienza University of Rome(IT)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Immune Cell Function and Interaction, Cancer Treatment and Pharmacology, Peptidase Inhibition and Analysis
Most-Cited Works
- → Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis(2017)674 cited
- → ATM-ATR–dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype(2008)431 cited
- → Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial(2010)425 cited
- → Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy(1990)385 cited
- → Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study(2020)380 cited